Addex Therapeutics (ADXN) Consolidated Net Income (2022 - 2025)
Historic Consolidated Net Income for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to $142225.5.
- Addex Therapeutics' Consolidated Net Income fell 9910.28% to $142225.5 in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 13717.79%. This contributed to the annual value of $13.6 million for FY2024, which is 25162.55% up from last year.
- As of Q2 2025, Addex Therapeutics' Consolidated Net Income stood at $142225.5, which was down 9910.28% from -$1.6 million recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Consolidated Net Income registered a high of $15.9 million during Q2 2024, and its lowest value of -$9.1 million during Q4 2023.
- In the last 4 years, Addex Therapeutics' Consolidated Net Income had a median value of -$2.2 million in 2023 and averaged -$1.1 million.
- Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 23781.34% in 2023, then soared by 76178.03% in 2024.
- Quarter analysis of 4 years shows Addex Therapeutics' Consolidated Net Income stood at $6.6 million in 2022, then tumbled by 237.81% to -$9.1 million in 2023, then skyrocketed by 99.8% to -$18155.9 in 2024, then skyrocketed by 883.36% to $142225.5 in 2025.
- Its Consolidated Net Income stands at $142225.5 for Q2 2025, versus -$1.6 million for Q1 2025 and -$18155.9 for Q4 2024.